PerkinElmer acquires in vivo molecular imaging developer VisEn Medical to emphasize cell research

Waltham, MA-based PerkinElmer, Inc. has acquired VisEn Medical, Inc., an in vivo molecular imaging technology company based in Bedford, MA,  to enhance its cellular imaging business by expanding the Company's technologies and capabilities downstream into preclinical research undertaken in academic institutes and pharmaceutical companies. VisEn's proprietary fluorescence molecular imaging systems and reagents are currently used in applications involving research into cancer, inflammation, cardiovascular, skeletal and pulmonary diseases.

Richard Eglen, president, Bio-discovery at PerkinElmer, notes that their drug disovery product offering will expand through the addition of proprietary chemistries in the emerging and fast-growing space of translational biomarker reagents.

The VisEn offering includes its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMT) Imaging Systems. These technologies provide quantitative molecular imaging data that can be useful for identifying and characterizing a range of disease biomarkers and therapeutic efficacy in cells and animal models. This cellular imaging approach, combined with PerkinElmer technologies, can enable screening and optimization of potential new drugs, through translational biomarker research. This can provide an increased correlation of isolated cellular activity with in vivo biological activity, which will allow researchers to get closer to understanding human responses and thereby develop potential therapies.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

New bioimaging technique offers clear view of nervous system

Scientists at Ludwig-Maximilians University have developed a technique for turning the body of a deceased rodent entirely transparent, revealing the central nervous system in unprecedented clarity....

Fluorescent jellyfish proteins light up unconventional laser

Safer lasers to map your cells could soon be in the offing -- all thanks to the humble jellyfish. Conventional lasers, like the pointer you might use to entertain your cat, produce light by emittin...

Fluorescence microscopy helps provide new insight into how cancer cells metastasize

By using fluorescence microscopy, scientists have discovered an alternate theory on how some cancer cells metastasize.

In vivo imaging method visualizes bone-resorbing cell function in real time

In vivo imaging can visualize sites where osteoclasts (bone-resorbing cells) were in the process of resorbing bone.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS